Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages
Open Access
- 15 April 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8) , 4084
Abstract
Mitocryptides are a novel family of endogenous neutrophil-activating peptides originating from various mitochondrial proteins. Mitocryptide-2 (MCT-2) is one of such neutrophil-activating peptides, and is produced as an N-formylated pentadecapeptide from mitochondrial cytochrome b. Although MCT-2 is a specific endogenous ligand for formyl peptide receptor 2 (FPR2), the chemical structure within MCT-2 that is responsible for FPR2 activation is still obscure. Here, we demonstrate that the N-terminal heptapeptide structure of MCT-2 with an N-formyl group is the minimum structure that specifically activates FPR2. Moreover, the receptor molecule for MCT-2 is suggested to be shifted from FPR2 to its homolog formyl peptide receptor 1 (FPR1) by the physiological cleavages of its C-terminus. Indeed, N-terminal derivatives of MCT-2 with seven amino acid residues or longer caused an increase of intracellular free Ca2+ concentration in HEK-293 cells expressing FPR2, but not in those expressing FPR1. Those MCT-2 derivatives also induced β-hexosaminidase secretion in neutrophilic/granulocytic differentiated HL-60 cells via FPR2 activation. In contrast, MCT-2(1–4), an N-terminal tetrapeptide of MCT-2, specifically activated FPR1 to promote those functions. Moreover, MCT-2 was degraded in serum to produce MCT-2(1–4) over time. These findings suggest that MCT-2 is a novel critical factor that not only initiates innate immunity via the specific activation of FPR2, but also promotes delayed responses by the activation of FPR1, which may include resolution and tissue regeneration. The present results also strongly support the necessity of considering the exact chemical structures of activating factors for the investigation of innate immune responses.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (19K05853, 17J11507)
This publication has 65 references indexed in Scilit:
- The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitisExperimental & Molecular Medicine, 2013
- Stimulated Human Mast Cells Secrete Mitochondrial Components That Have Autocrine and Paracrine Inflammatory ActionsPLOS ONE, 2012
- Formyl Peptide Receptor Ligands Promote Wound Closure in Lung Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Mitocryptide-2, a neutrophil-activating cryptide, is a specific endogenous agonist for formyl-peptide receptor-like 1Biochemical and Biophysical Research Communications, 2011
- Mitochondrial Damage Associated Molecular Patterns From Femoral Reamings Activate Neutrophils Through Formyl Peptide Receptors and P44/42 MAP KinaseJournal of Orthopaedic Trauma, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Discovery of Mitocryptide-1, a Neutrophil-activating Cryptide from Healthy Porcine HeartJournal of Biological Chemistry, 2008
- A mastoparan analog without lytic effects and its stimulatory mechanisms in mast cellsBiochemical and Biophysical Research Communications, 2007
- Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNABiochemical and Biophysical Research Communications, 1990
- Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytesBiochemical and Biophysical Research Communications, 1987